In February 2020 the International Skating Union (ISU) has reported an anti-doping rule violation against the American skater Chrysta Rands after her sample tested positive for the prohibited substance Canrenone. After notification the Athlete filed a statement in her defence and she was heard for the ISU Disciplinary Commission.
The Athlete gave a prompt admission and denied the intentional use of the substance. She requested for a reduced santion and argued that she was tested before without issues. She explained with medical information that during the season she had used the medication Spironolactone prescribed by her dermatologist as treatment for her adult acne.
Both the Athlete and her dermatologist were unaware that this medication contained a prohibited substance. She acknowledged that she had not checked her medication before using and that she forgot to mention her acne medication on the Doping Control Form.
The Disciplinary Commission concludes that the Athlete had committed an anti-doping rule violation as a result of her use of a prescribed medication without a TUE. The Commission accepts that the violation was not intentional and that the Athlete established grounds for No Significant Fault or Negligence.
Therefore the ISU Disciplinary Commission decides on 15 May 2020 to impose a reduced sanction on the Athlete starting on the date of the sample collection, i.e. 2 February 2020, and ending on 31 December 2020.
